Blood-group phenotypes, sulfomucins, and Helicobacter pylori in Barrett's esophagus

American Journal of Surgical Pathology

Volumn 21, Issue 9, 1997, Pages 1023-1029

  Torrado, Julio ^a   Ruiz, Bernardo ^b   Garay, Jone ^a   Asenjo, Juan López G ^c   Tovar, Juan A ^d   Cosme, Angel ^a   Correa, Pelayo ^b  

^a Hospital Nuestra Senora de Aranzazu   (Spain)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

ABO blood group system; Barrett's esophagus; Esophageal adenocarcinoma; Helicobacter pylori; Lewis blood group system; Secretor status; Sulfomucins

Indexed keywords

MUCIN; SULFOMUCIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; BLOOD GROUP LEWIS SYSTEM; ESOPHAGUS CARCINOMA; GENETIC SUSCEPTIBILITY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PHENOTYPE;

ABO BLOOD-GROUP SYSTEM; ADENOCARCINOMA; AGED; BARRETT ESOPHAGUS; BLOOD GROUP ANTIGENS; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; LEWIS BLOOD-GROUP SYSTEM; MALE; MIDDLE AGED; MUCINS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030885621     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199709000-00006     Document Type: Article

References (36)

1. Abbas Z, Hussainy AS, Ibrahim F, Jafri SM, Shaikh H, Khan AH. Barrett's oesophagus and Helicobacter pylori. J Gastroenterol Hepatol 1995;10:331-3.
2. Bancroft JD, Stevens A, eds. Theory and Practice of Histological Techniques. 3rd ed. Edingburgh: Churchill Livingstone, 1990.
3. Bara J. Organ specific mucin antigens and gastrointestinal carcinogenesis. Ital J Gastroenterol 1991;23:29-35.
4. Billingtun BP, Sydney MB. Gastric cancer: relationships between ABO blood-groups, site, and epidemiology. Lancet 1956;2:859-62.
5. Calderon R, Campillo F, Escudero MC, Gallardo L. Lewis phenotypes and secretor character in the Castilla la Nueva-region (Spain): ABH and Lewis antigen levels in salivary secretion. Anthropol Anz 1984;42:31-9.
6. Calderon R, Vidales C.,Rebato E, Pena JA. ABH antigen secretion in Basques and the spatial variation pattern of the secretor locus in Spain. Gene Geogr 1991:61-8.
7. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985;313:857-9.
8. Coon JS, Weinstein RS. Blood group-related antigens as markers of malignant potential and heterogeneity in human carcinomas. Hum Pathol 1986;17:1089-106.
9. Correa P. Helicobacter pylori and gastric carcinogencsis. Am J Surg Pathol 1995;19(Suppl 1):S37-43.
10. Davidson JS, Triadafilopoulos G. Blood group-related antigen expression in normal and metaplastic human upper gastrointestinal mucosa. Gastroenterology 1992;103:1552-61.
11. Feizi T. Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are oncodevelopmental antigens. Nature 1985;314:53-7.
12. Filipe MI, Jass JR. Intestinal metaplasia subtypes and cancer risk. In: Filipe MI, Jass JR, eds. Gastric carcinoma. Edinburgh: Churchill Livingstone. 1986;87-115.
13. Filipe MI. Muñoz N, Matko I, et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 1994;57:324-9.
14. Fontham ETH, Ruiz B. Perez A, Hunter F, Correa P. Determinants of Helicobacter pylori infection and chronic gastritis. Am J Gastroenterol 1995;90:1094-100.
15. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994;25:982-93.
16. Haggitt RC, Reid BJ, Rabinovitch PS, Rubin CE. Barrett's esopha- gus: correlation between mucin histochemistry. How cytometry, and histologic diagnosis for predicting increased cancer risk. Am J Pathol 1988;131:53-61.
17. Houck JA, Lucas JG, Kalogeropoulos NK, Whitehead R. Absence of Campylobacter-like organisms in Barrett's esophagus. Arch Pathol Lab Med 1989;113:470-2.
18. Jass JR. Mucin histochemistry of the columnar epithelium of the oesophagus: a retrospective study. J Clin Pathol 1981;34:866-70.
19. Lapertosa G, Baracchini P, Fulcheri E. Mucin histochemical analysis in the interpretation of Barrett's esophagus: results of a multicenter study. The Operative Group for the Study of Esophageal Precancer. Am J Clin Pathol 1992;98:61-6.
20. Li H. Malignant Barrett's oesophagus. Eur J Cancer Prev 1993;2:47-52.
21. Loffeld RJ, Ten TBJ, Arends JW. Prevalence and significance of Helicobacter pylori in patients with Barretts esophagus. Am J Gastroenterol 1992;87:1598-600.
22. b) and type 2 (X, Y, H) blood group-related antigens in the human pyloric and duodenal mucosae. Lab Invest 1985;53:219-27.
23. Mollicone R, Le Pendu J, Bara J, Oriol R. Heterogeneity of the ABH antigenic determinants expressed in human pyloric and duodenal mucosae. Glycoconjugate 1986;3:187-202.
24. Mourant AE, Kopec AC, Domaniewska-Sobczak K. Blood Groups and Diseases: A Study of Association of Diseases with Blood Groups and Other Polymorphisms. Oxford: Oxford University Press, 1978.
25. Oriol R, Gane P, Rouger PH, Mollicone R. Inhibition of haemagglutination with Synsorbs and saliva of monoclonal antibodies against non-A non-B glycoconjugates. Rev Fr Transfus Immunohematol 1987;30:671-80.
26. Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK. The histological spectrum of Barrett's esophagus. N Engl J Med 1976;295:476-80.
27. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-3.
28. Prophet EB, Mills B, Arrington JB, Sobin LH, eds. Laboratory Methods in Histotechology: Armed Forces Institute of Pathology. Washington. DC: American Registry of Pathology, 1994.
29. Spechler SJ. Barrett's esophagus. Semin Oncol 1994;21:431-7.
30. Spicer SS. Diamine methods for differentiating mucosubstances histochemically. J Histochem Cytochem 1964;13:211-34.
31. Talley NJ, Cameron AJ, Shorter RG, Zinsmeister AR, Phillips SF. Campylobacter pylori and Barrett's esophagus. Mayo Clin Proc 1988;63:1176-80.
32. Torrado J. Blasco E, Cosme A, Gutierrez-Hoyos A, Arenas JI. Expression of type 1 and type 2 blood group-related antigens in normal and neoplastic gastric mucosa. Am J Clin Pathol 1989;91:249-54.
33. Torrado J, Blaseo E, Cosme A, Gutierrez-Hoyos A, Arenas JI, Cuadrado E. Immunohistologic reactions of 20 monoclonal antibodies against non-A, non-B glycocojugates with normal mucosa of the human gut. Rev Fr Transfus Immunohematol 1987;30:693-8.
34. Torrado J, Correa P, Ruiz B, Bernardi P, Zavala D, Bara J. Lewis antigen alterations in gastric cancer precursors. Gastroenterology 1992;102:424-30.
35. Torrado J, Correa P, Ruiz. B, Zavala D, Bara J. Prospective study of Lewis antigen alterations in the gastric precancerous process. Cancer Epidemiol Biomarkers Prev 1992;1:199-205.
36. Watkins WM. Biochemistry and genetics of the ABO, Lewis, and P blood group systems. Adv Hum Genet 1980;10:1-136.